1980
DOI: 10.1128/jcm.12.2.140-143.1980
|View full text |Cite
|
Sign up to set email alerts
|

Chemiluminescence-linked immunoassay for detection of mumps virus antibodies

Abstract: We have developed a simple and sensitive chemiluminescence-linked immunoassay (CLIA) for determining mumps virus antibodies. Luminol molecules were used as markers, and polystyrene balls were used as antigen carriers. The CLIA was compared with an enzyme-linked fluorescence assay and a hemagglutination inhibition test on a total of 40 serum specimens obtained from 29 donors with natural infection or vaccination. There was good correlation between the three methods, and the sensitivity of the CLIA was about 10 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1983
1983
1991
1991

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Efficient enzymatic labels generating products, such as fluorescent (3, 4, 7-10, 12, 14, 25, 35), chemiluminescent (15), or radioactive (11) compounds, that are measurable at lower concentrations than visibly colored products could provide an alternative to increase the sensitivity of EIA. Enzymatically amplified cycling reaction represents another method of magnifying the signal produced by enzymatic reactions (16,17,19,28).…”
mentioning
confidence: 99%
“…Efficient enzymatic labels generating products, such as fluorescent (3, 4, 7-10, 12, 14, 25, 35), chemiluminescent (15), or radioactive (11) compounds, that are measurable at lower concentrations than visibly colored products could provide an alternative to increase the sensitivity of EIA. Enzymatically amplified cycling reaction represents another method of magnifying the signal produced by enzymatic reactions (16,17,19,28).…”
mentioning
confidence: 99%
“…Other improvements in the development of immunoassay technology have been described, and they include the use of fluorescent substrates (85,148), chemiluminescent labels (129), radioactive substrates (59) , and biotin-avidin linked systems. The improvement of sensitivity and speci ficity through the use of monoclonal antibodies has also been investigated.…”
Section: Immunoassaysmentioning
confidence: 99%